|
|
|
SENSEX
|
|
86.40
|
0.37%
|
23249.50
|
|
|
NIFTY
|
|
226.85
|
0.30%
|
76759.81
|
|
|
Nasdaq
|
|
-101.27
|
-0.51%
|
19632.32
|
|
|
Nikkei 225
|
|
397.91
|
1.02%
|
39414.78
|
|
|
FTSE 100
|
|
23.90
|
0.28%
|
8557.80
|
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Cipla |
BSE Code |
500087
|
ISIN Demat |
INE059A01026
|
Book Value (Rs) |
378.55
|
|
NSE Code |
CIPLA
|
Dividend Yield % |
0.89
|
Market Cap (Rs) |
1177622.41
|
|
TTM PE(x) |
25.30
|
TTM EPS(Rs) |
57.63
|
Face Value(Rs.) |
2
|
|
|
|
|
|
|
Incorporation Year
|
17-08 1935
|
Registered Office
|
Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel, Mumbai, Maharashtra-400013 .
|
ISINNO
|
INE059A01026
|
Phone
|
022-24826000
|
E-mail
|
contactus@cipla.com |
URL
|
www.cipla.com |
Industry
|
Pharmaceuticals & Drugs
|
Chairman
|
Y K Hamied
|
Managing Director
|
Umang Vohra
|
Company Secretary
|
Rajendra Chopra
|
Listing
|
BSE,NSE,Luxembourg
|
|
|
|
|
|
|
|
|
|
|
|